Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation

Objectives: To assess the clinical effectiveness and cost-effectiveness of bevacizumab, combined with interferon (IFN), sorafenib tosylate, sunitinib and temsirolimus in the treatment of people with advanced and/or metastatic renal cell carcinoma (RCC). Data sources: Electronic databases, including...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: J Thompson Coon, M Hoyle, C Green, Z Liu, K Welch, T Moxham, K Stein
Formáid: Artigo
Teanga:Inglês
Foilsithe: NIHR Journals Library 2010-01-01
Sraith:Health Technology Assessment
Ábhair:
bevacizumab
sorafenib-tosylate
sunitinib
temsirolimus
renal-cell-carcinoma
systematic-review
economic-evaluation
Rochtain Ar Líne:https://doi.org/10.3310/hta14020
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla